Cargando…
Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer
BACKGROUND: Doppler ultrasonography (US) is increasingly being utilized as an imaging modality in breast cancer. It is used to study the vascular characteristics of the tumor. Neoadjuvant chemotherapy is the standard modality of treatment in locally advanced breast cancer. Histological examination r...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008196/ https://www.ncbi.nlm.nih.gov/pubmed/17725837 http://dx.doi.org/10.1186/1477-7819-5-99 |
_version_ | 1782135865798033408 |
---|---|
author | Kumar, Anand Singh, Seema Pradhan, Satyajit Shukla, Ram C Ansari, Mumtaz A Singh, Tej B Shyam, Rohit Gupta, Saroj |
author_facet | Kumar, Anand Singh, Seema Pradhan, Satyajit Shukla, Ram C Ansari, Mumtaz A Singh, Tej B Shyam, Rohit Gupta, Saroj |
author_sort | Kumar, Anand |
collection | PubMed |
description | BACKGROUND: Doppler ultrasonography (US) is increasingly being utilized as an imaging modality in breast cancer. It is used to study the vascular characteristics of the tumor. Neoadjuvant chemotherapy is the standard modality of treatment in locally advanced breast cancer. Histological examination remains the gold standard to assess the chemotherapy response. However, based on the color Doppler findings, a new scoring system that could predict histological response following chemotherapy is proposed. METHODS: Fifty cases of locally advanced infiltrating duct carcinoma of the breast were studied. The mean age of the patients was 44.5 years. All patients underwent clinical, Doppler and histopathological assessment followed by three cycles of CAF (Cyclophosphamide, Adriamycin and 5-Fluorouracil) chemotherapy, repeat clinical and Doppler examination and surgery. The resected specimens were examined histopathologically and histological response was correlated with Doppler findings. The Doppler characteristics of the tumor were graded as 1–4 for <25%, 25–50%, >50% and complete disappearance of flow signals respectively. A cumulative score was calculated and compared with histopathological response. Results were analyzed using Chi square test, sensitivity, specificity, positive and negative predictive values. RESULTS: The maximum Doppler score according to the proposed scoring system was twelve and minimum three. Higher scores corresponded with a more favorable histopathological response. Twenty four patients had complete response to chemotherapy. Sixteen of these 24 patients (66.7%) had a cumulative Doppler score more than nine. The sensitivity of cumulative score >5 was 91.7% and specificity was 38.5%. The area under the ROC curve of the cumulative score >9 was 0.72. CONCLUSION: Doppler scoring can be accurately used to objectively predict the response to chemotherapy in patients with locally advanced breast cancer and it correlates well with histopathological response. |
format | Text |
id | pubmed-2008196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-20081962007-10-10 Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer Kumar, Anand Singh, Seema Pradhan, Satyajit Shukla, Ram C Ansari, Mumtaz A Singh, Tej B Shyam, Rohit Gupta, Saroj World J Surg Oncol Technical Innovations BACKGROUND: Doppler ultrasonography (US) is increasingly being utilized as an imaging modality in breast cancer. It is used to study the vascular characteristics of the tumor. Neoadjuvant chemotherapy is the standard modality of treatment in locally advanced breast cancer. Histological examination remains the gold standard to assess the chemotherapy response. However, based on the color Doppler findings, a new scoring system that could predict histological response following chemotherapy is proposed. METHODS: Fifty cases of locally advanced infiltrating duct carcinoma of the breast were studied. The mean age of the patients was 44.5 years. All patients underwent clinical, Doppler and histopathological assessment followed by three cycles of CAF (Cyclophosphamide, Adriamycin and 5-Fluorouracil) chemotherapy, repeat clinical and Doppler examination and surgery. The resected specimens were examined histopathologically and histological response was correlated with Doppler findings. The Doppler characteristics of the tumor were graded as 1–4 for <25%, 25–50%, >50% and complete disappearance of flow signals respectively. A cumulative score was calculated and compared with histopathological response. Results were analyzed using Chi square test, sensitivity, specificity, positive and negative predictive values. RESULTS: The maximum Doppler score according to the proposed scoring system was twelve and minimum three. Higher scores corresponded with a more favorable histopathological response. Twenty four patients had complete response to chemotherapy. Sixteen of these 24 patients (66.7%) had a cumulative Doppler score more than nine. The sensitivity of cumulative score >5 was 91.7% and specificity was 38.5%. The area under the ROC curve of the cumulative score >9 was 0.72. CONCLUSION: Doppler scoring can be accurately used to objectively predict the response to chemotherapy in patients with locally advanced breast cancer and it correlates well with histopathological response. BioMed Central 2007-08-28 /pmc/articles/PMC2008196/ /pubmed/17725837 http://dx.doi.org/10.1186/1477-7819-5-99 Text en Copyright © 2007 Kumar et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Technical Innovations Kumar, Anand Singh, Seema Pradhan, Satyajit Shukla, Ram C Ansari, Mumtaz A Singh, Tej B Shyam, Rohit Gupta, Saroj Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer |
title | Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer |
title_full | Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer |
title_fullStr | Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer |
title_full_unstemmed | Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer |
title_short | Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer |
title_sort | doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer |
topic | Technical Innovations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008196/ https://www.ncbi.nlm.nih.gov/pubmed/17725837 http://dx.doi.org/10.1186/1477-7819-5-99 |
work_keys_str_mv | AT kumaranand dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer AT singhseema dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer AT pradhansatyajit dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer AT shuklaramc dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer AT ansarimumtaza dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer AT singhtejb dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer AT shyamrohit dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer AT guptasaroj dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer |